Atlassian
TEAM Nasdaq Application Software Financials FY2017βFY2026
Atlassian's revenue rose 26.0% to $6.6 billion in fiscal 2026. Its operating margin was 0.2%, up from β2.5% a year earlier. Free cash flow was $1.3 billion, down 6.8%. It paid out $1.8 billion in dividends and buybacks, 136% of free cash flow. The diluted share count fell 0.6%.
What Atlassian does
Atlassian sells software that helps teams plan, track and carry out their work. It was founded in Sydney, Australia, in 2002. Its products serve software teams, IT operations and support teams, and business and leadership teams. Its best-known apps include Jira, Confluence and Jira Service Management. They run on a shared cloud platform, and the company has added artificial intelligence (AI) features, including an AI offering it calls Rovo.
Atlassian says it serves more than 350,000 customers, from small companies to over 85% of the Fortune 500, in over 200 countries and territories. It earns its revenue by selling subscriptions and licenses to its software. Many customers sign up on their own through self-service, and the company's sales force focuses mainly on deepening relationships with large business customers. It also runs the Atlassian Marketplace, where outside developers sell apps that work with its products.
The company says it derives a majority of its revenue from Jira, Confluence and Jira Service Management. It is moving its business toward its cloud offerings, and it competes in markets it describes as intensely competitive.
- Legal name
- Atlassian Corporation
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K Β· Aug 14, 2026
- Accession Β· CIK
- 0001650372-26-000036
0001650372
Revenue and margins
Atlassian had $6.6B of revenue in fiscal 2026, up 26.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.3B in fiscal 2026, 20.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Atlassian returned $1.8B to shareholders in fiscal 2026, 137% of free cash flow. The diluted share count fell 0.6%.
Value Atlassian yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $250M and divides by 260.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably Atlassian can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.5B | $2.1B | $2.3B | $2.9B | $1.2B |
| Debt incl. finance leases | $999M | $1,000M | $986M | $988M | $990M |
| Net debt / EBITDA | β3.8x | β | β | β | β1.7x |
| Debt / equity | 3.1x | 1.5x | 1.0x | 0.7x | 0.9x |
| Interest coverage | 1.7x | β11.5x | β3.4x | β4.3x | 0.2x |
| Current ratio | 1.2x | 1.4x | 1.2x | 1.2x | 0.8x |
| Quick ratio | 1.2x | 1.4x | 1.2x | 1.2x | 0.8x |
| Total assets | $3.3B | $4.1B | $5.2B | $6.0B | $6.1B |
| Total liabilities | $3.0B | $3.5B | $4.2B | $4.7B | $5.0B |
| Shareholders' equity | $327M | $655M | $1.0B | $1.3B | $1.1B |
| Net debt (β = net cash) | β$459M | β$1.1B | β$1.4B | β$1.9B | β$250M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$4.5M
3 insiders
Of sales under plans
31%
$1.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Gene LiuChief Accounting Officer | Sold plan | 337 | $210.00 | $0.1M | Form 4 |
| Aug 28, 2026 | Gene LiuChief Accounting Officer | Sold plan | 939 | $190.00 | $0.2M | Form 4 |
| Aug 19, 2026 | Brian DuffyChief Revenue Officer | Sold | 1,851 | $172.45 | $0.3M | Form 4 |
| Aug 19, 2026 | Gene LiuChief Accounting Officer | Sold plan | 1,125 | $175.00 | $0.2M | Form 4 |
| Aug 19, 2026 | James ChuongChief Financial Officer | Sold | 9,054 | $172.45 | $1.6M | Form 4 |
| Aug 14, 2026 | Brian DuffyChief Revenue Officer | Sold | 7,617 | $163.00 | $1.2M | Form 4 |
| Aug 14, 2026 | Gene LiuChief Accounting Officer | Sold plan | 815 | $163.00 | $0.1M | Form 4 |
| Aug 13, 2026 | Gene LiuChief Accounting Officer | Sold plan | 737 | $165.00 | $0.1M | Form 4 |
| Jun 12, 2026 | Brian DuffyChief Revenue Officer | Sold plan | 3,000 | $89.71 | $0.3M | Form 4 |
| Jun 11, 2026 | Brian DuffyChief Revenue Officer | Sold plan | 1,432 | $88.79 | $0.1M | Form 4 |
| Jun 10, 2026 | Brian DuffyChief Revenue Officer | Sold plan | 1,813 | $92.79 | $0.2M | Form 4 |
| Jun 9, 2026 | Brian DuffyChief Revenue Officer | Sold plan | 1,454 | $95.35 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 9 | 6 / 9 | 7 / 9 |
| Accruals ratio | β37.5% | β30.5% | β23.2% |
| Altman Z'' | β1.31 | β1.36 | β3.86 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Atlassian TEAM | $59.2B | 26.0% | 0.2% | 20.1% | β | β | 7 | |
| Synopsys SNPS | $82.7B | 15.1% | 13.0% | 19.1% | 4.0% | 75.2x | 3 | Compare β |
| Autodesk ADSK | $53.2B | 17.5% | 21.9% | 33.4% | 37.0% | 32.7x | 8 | Compare β |
| Cadence Design Systems CDNS | $86.6B | 14.1% | 28.2% | 30.0% | 23.7% | 73.8x | 5 | Compare β |
| OpenText OTEX | $7.0B | 1.5% | 20.6% | 15.4% | 9.0% | β | 9 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $620M | $874M | $1.2B | $1.6B | $2.1B | $2.8B | $3.5B | $4.4B | $5.2B | $6.6B |
| Gross profit | $508M | $708M | $1,000M | $1.3B | $1.8B | $2.4B | $2.9B | $3.6B | $4.3B | $5.6B |
| Research and development | $310M | $416M | $579M | $763M | $933M | $1.3B | $1.9B | $2.2B | $2.7B | $3.3B |
| Operating income | β$55.8M | β$46.0M | β$63.4M | $14.1M | $141M | $70.1M | β$345M | β$117M | β$130M | $10.4M |
| Interest expense | $0.1M | $6.8M | $40.2M | $49.6M | $92.6M | $41.5M | $30.1M | $34.1M | $30.5M | $49.4M |
| Pretax income | β$52.4M | β$58.1M | β$606M | β$346M | β$514M | β$471M | β$311M | β$85.4M | β$98.9M | $22.1M |
| Income tax | β$15.0M | $55.3M | $32.1M | $4.4M | $64.6M | $48.6M | $176M | $215M | $158M | $75.9M |
| Net income | β$37.4M | β$113M | β$638M | β$351M | β$579M | β$520M | β$487M | β$301M | β$257M | β$53.8M |
| Diluted EPS | β$0.17 | β$0.49 | β$2.67 | β$1.43 | β$2.32 | β$2.05 | β$1.90 | β$1.16 | β$0.98 | β$0.21 |
| Diluted shares | 0.22B | 0.23B | 0.24B | 0.24B | 0.25B | 0.25B | 0.26B | 0.26B | 0.26B | 0.26B |
| Cash flow | ||||||||||
| Cash from operations | $199M | $312M | $466M | $574M | $790M | $821M | $868M | $1.4B | $1.5B | $1.4B |
| Capital expenditure | $0.9M | $30.2M | $44.2M | $35.7M | $31.5M | $70.6M | $25.8M | $33.1M | $44.9M | $34.1M |
| Free cash flow | $198M | $281M | $422M | $539M | $758M | $750M | $842M | $1.4B | $1.4B | $1.3B |
| Depreciation and amortization | $61.5M | $79.4M | $70.2M | $62.3M | $55.9M | $51.7M | $60.9M | $78.7M | $92.4M | $141M |
| Stock-based compensation | $137M | $163M | $258M | $313M | $341M | $525M | $948M | $1.1B | $1.4B | $1.6B |
| Acquisitions | $381M | $0.0M | $419M | $53.2M | $91.8M | $19.4M | $5.8M | $848M | $14.2M | $1.2B |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $150M | $395M | $779M | $1.8B |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $150M | $395M | $779M | $1.8B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $550M | $1.7B | $1.7B | $2.2B | $1.2B | $1.5B | $2.1B | $2.3B | $2.9B | $1.2B |
| Total debt | $0.0M | $820M | $854M | $889M | $349M | $999M | $1,000M | $986M | $988M | $990M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $613M | $1.8B | $2.0B | $2.6B | $1.6B | $1.9B | $2.7B | $3.1B | $3.9B | $2.8B |
| Current liabilities | $327M | $445M | $2.3B | $3.0B | $2.3B | $1.6B | $2.0B | $2.6B | $3.2B | $3.6B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $41.2M | $51.7M | $81.5M | $97.6M | $66.2M | $101M | $81.4M | $86.3M | $105M | $86.3M |
| Total assets | $1.3B | $2.4B | $3.0B | $3.9B | $2.9B | $3.3B | $4.1B | $5.2B | $6.0B | $6.1B |
| Total liabilities | $390M | $1.5B | $2.4B | $3.3B | $2.7B | $3.0B | $3.5B | $4.2B | $4.7B | $5.0B |
| Shareholders' equity | $903M | $907M | $566M | $567M | $313M | $327M | $655M | $1.0B | $1.3B | $1.1B |
| Margins | ||||||||||
| Gross margin | 81.9% | 81.0% | 82.6% | 83.4% | 84.1% | 83.8% | 82.1% | 81.6% | 82.8% | 84.8% |
| Operating margin | β9.0% | β5.3% | β5.2% | 0.9% | 6.8% | 2.5% | β9.8% | β2.7% | β2.5% | 0.2% |
| EBITDA margin | 0.9% | 3.8% | 0.6% | 4.7% | 9.5% | 4.4% | β8.0% | β0.9% | β0.7% | 2.3% |
| Net margin | β6.0% | β13.0% | β52.7% | β21.7% | β27.7% | β18.5% | β13.8% | β6.9% | β4.9% | β0.8% |
| FCF margin | 32.0% | 32.2% | 34.9% | 33.4% | 36.3% | 26.8% | 23.8% | 32.5% | 27.1% | 20.1% |
| Returns | ||||||||||
| Return on capital employed | β | β3.1% | β4.8% | 1.9% | 18.7% | 5.9% | β18.1% | β5.0% | β4.8% | 0.4% |
| Return on equity | β | β12.5% | β86.6% | β62.0% | β131.6% | β162.2% | β99.1% | β35.6% | β21.6% | β4.5% |
| Return on assets | β | β6.1% | β23.6% | β10.2% | β16.9% | β16.6% | β13.1% | β6.5% | β4.6% | β0.9% |
| Growth | ||||||||||
| Revenue growth | 35.6% | 41.0% | 38.5% | 33.4% | 29.4% | 34.2% | 26.1% | 23.3% | 19.7% | 26.0% |
| Net income growth | β956.4% | β | β | β | β | β | β | β | β | β |
| EPS growth | β950.0% | β | β | β | β | β | β | β | β | β |
| FCF growth | 108.2% | 41.7% | 50.1% | 27.6% | 40.8% | β1.1% | 12.2% | 68.0% | 0.0% | β6.8% |
| Share count change | 14.9% | 4.0% | 3.2% | 2.6% | 2.0% | 1.5% | 1.2% | 1.1% | 1.0% | β0.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | β96.3x | β27.4x | β124.9x | β16.6x | β4.5x | β3.8x | β | β | β | β1.7x |
| Debt / equity | 0.0x | 0.9x | 1.5x | 1.6x | 1.1x | 3.1x | 1.5x | 1.0x | 0.7x | 0.9x |
| Interest coverage | β744.5x | β6.8x | β1.6x | 0.3x | 1.5x | 1.7x | β11.5x | β3.4x | β4.3x | 0.2x |
| Current ratio | 1.9x | 4.1x | 0.9x | 0.9x | 0.7x | 1.2x | 1.4x | 1.2x | 1.2x | 0.8x |
| Quick ratio | 1.9x | 4.1x | 0.9x | 0.9x | 0.7x | 1.2x | 1.4x | 1.2x | 1.2x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.2% | 3.5% | 3.7% | 2.2% | 1.5% | 2.5% | 0.7% | 0.8% | 0.9% | 0.5% |
| Stock comp / revenue | 22.2% | 18.6% | 21.3% | 19.4% | 16.3% | 18.7% | 26.8% | 24.8% | 26.1% | 24.4% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 17.8% | 27.9% | 55.1% | 136.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 4.0 | 6.0 | 4.0 | 4.0 | 6.0 | 4.0 | 6.0 | 7.0 |
| Altman Z'' | 3.5 | 4.1 | β1.4 | β1.4 | β3.1 | β1.0 | β1.2 | β1.3 | β1.4 | β3.9 |
| Accruals ratio | β | β22.9% | β40.9% | β26.9% | β40.0% | β42.8% | β36.5% | β37.5% | β30.5% | β23.2% |
Source: SEC EDGAR XBRL filings (CIK 0001650372). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.